Blood levels of three biomarkers — clusterin (CLU), neurofilament light chain (NfL), and low-density lipoprotein cholesterol (LDL-C) — may help…
Articles by Andrea Lobo
Starting rehabilitation within the first year after a Parkinson’s disease diagnosis may be associated with longer survival, even among…
People with depressive symptoms may have higher odds of developing Parkinson’s disease, a large study suggests, with the researchers…
Neuralight’s eye-movement biomarkers may predict declines in daily functioning in people…
The U.S. Food and Drug Administration (FDA) has awarded fast-track designation — a status that aims to speed the development…
People with Parkinson’s disease who participated in a U.K. study said maintaining their oral health helped preserve their independence…
Georgia has expanded its medical cannabis program, allowing registered patients ages 21 and older to access medical cannabis flower and…
Mighty Therapeutics, a Massachusetts-based biotech company, announced that it has raised $150 million to support the clinical development of…
An investigational stem cell-based therapy that would replace the nerve cells, or neurons, lost due to Parkinson’s disease was…
Kenai Therapeutics has completed patient enrollment in a small, early clinical trial testing the safety and effectiveness of RNDP-001,…